A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis Bullosa
Phase 2
- Conditions
- Epidermolysis Bullosa
- Registration Number
- JPRN-UMIN000026645
- Lead Sponsor
- Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who received a therapy with mesenchymal stem cell derived from human bone marrow or TEMUCELL HS injection. 2) Patients who are suffering from serious mental diseases. 3) Patients who are suffering from cancer or who have histories of suffering from cancer within 5 years prior to enrollment. 4) Patients who are pregnant or probably pregnant. 5) Patients who do not agree to take effective contraceptive measures during the study period. 6) Patients who have entered other clinical trials within 6 months prior to enrollment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method